Peginterferon - ViRexx Announces Collaboration with Defence Research and ...

ViRexx Announces Collaboration with Defence Research and ...
CCNMatthews (press release), Canada - Mar 31, 2006... The Company is also conducting preclinical studies on Chimigen TM therapeutic vaccine candidates to treat chronic hepatitis C infections. ...

Novartis Announces in-licensing of Valopicitabine (NM283), a Novel ...
PharmaLive.com (press release), PA - Mar 29, 2006... its option from Idenix Pharmaceuticals to in-license the late-stage development compound valopicitabine (NM283) for the treatment of hepatitis C, a condition ...

Hepatitis C Market: Plenty Of Potential, But Little Progress
Investor's Business Daily (subscription) - Mar 31, 2006The month of March was not kind to a pair of companies racing to find a cure or vaccine for hepatitis C, the often fatal liver disease that's been called a ...

Gastroenterology issues probed
Trade Arabia, Bahrain - Apr 1, 2006A variety of topics spanning from transplantation procedures to Hepatitis C disease were the focus of a recent forum in Sharjah, UAE. ...

Life sentence for man who killed in Aids blunder
Yorkshire Post Today, UK - Apr 5, 2006... with alcohol. That led to mental problems and she also contracted hepatitis C, although, at the time, it was in remission. She moved ...

Shares in Swedish biotech firm Tripep fall
Reuters - Apr 4, 2006... It said it was hard to see a continuation of the study of the drug and would instead concentrate on ChronVac-C against Hepatitis C Virus infections. ...